The aim of our study was to evaluate the impact of late referral (LR) on health parameters and mortality rate of chronic kidney disease (CKD) patients.
Introduction
The burden of chronic kidney diseases (CKD) is increasing and has been linked to an epidemic. The number of patients with end-stage renal disease (ESRD) in Europe and the USA has doubled in the last two decades because of the ageing population and the epidemic of type 2 diabetes. It is estimated that the number will not plateau for the next two decades [1] . CKD carries with it not only the risk for progression to ESRD but also the risk for increased morbidity and mortality from cardiovascular disease. Indeed, it is more likely that a patient with CKD of stages 3-5 will die of cardiovascular disease rather than progress to dialysis. CKD does not affect all sectors of the population equally, with a higher prevalence among the elderly [2] .
Observational studies and their meta-analysis have shown that late referral (LR) of patients with CKD to nephrologists is associated with poor clinical outcomes. Longer predialysis care by nephrologists may result in a reduction in the rate of hospitalization and mortality There is no universally accepted definition for 'late referral' of patients with CKD. Several inconsistent criteria including the number of months before the initiation of dialysis (1, 3, or 6 months) or the stage of CKD have been used to define LR of patients with CKD [3, 4] . The National Kidney Foundation -Kidney Disease Outcomes Quality Initiatives guidelines recommend that patients with CKD be referred to nephrologists when the glomerular filtration rates (GFRs) fall below 30 ml/min (stage 4 CKD), and earlier if possible [5] .
This inconsistency in the definition of LR is attributable to changing practice patterns among physicians, changes in the definition of CKD, and increasing awareness among physicians and patients. The optimal timing of referral varies depending on the physicians' characteristics and preferences, practice setting, comfort level of the treating physician, and the availability of nephrologists. However, later referral to nephrology care could be defined as referral occurring within 4 months of ESRD and in terms of the proportion of patients starting hemodialysis with a mature arteriovenous fistula and starting dialysis in the outpatient setting [6] [7] [8] .
LR of patients with advanced renal disease is associated with significant morbidity and mortality and compromises preparations for dialysis. It also incurs greater costs than more timely referral [9] [10] [11] . The current single-center retrospective study aimed to evaluate the impact of LR on health parameters and concomitant mortality rate of CKD patients.
Patients and methods
The current study was conducted at the Nephrology Department of Ibn Sina College of Medicine, Jeddah, KSA, from January 2009 to December 2012. Data were collected from the files of patients referred to the Renal Replacement Therapy (RRT) Unit. Patients were classified as early referrals (ERs) if their first encounter with a nephrologist was within 16 weeks before initiation of dialysis, and all others patients were considered LRs [12] . Estimated GFR (eGFR) was calculated using the modified Modification of Diet in Renal Disease equation [13] , as follows: eGFR (ml/min/1.73m
2 ) = 186.3 × (serum creatinine in mg/dl) −1.154 × (ageinyear) −0.203 (×0.742 for female individuals)
Data collection
Evaluated parameters included age, sex, BMI measures -that is, weight and height -and calculated BMI. Underlying kidney diseases including diabetes mellitus, hypertension, glomerulonephritis, polycystic kidney disease, and other known or unknown kidney diseases were evaluated for. The modified Charlson comorbidity index (CCI) was calculated [14] . Data from clinical examination were verified with special reference to associated comorbidities and determination of blood pressure measures. Laboratory data including hemoglobin concentration; lipid profile; and uric acid, calcium, and phosphate levels were revised.
The outcome of the study is presented as the followup mortality rate in both ER and LR groups and its relationship with the timing of referral and collected data.
Statistical analysis
Obtained data are presented as mean ± SD, ranges, numbers, percentages, and ratios. Results were analyzed using Wilcoxon's ranked test for unrelated data (Z-test) and c 2 -test. Possible relationships were investigated using Pearson's linear regression. The receiver operating characteristic curve was used to evaluate various parameters as predictors for survival. Analysis was judged by the area under the curve (AUC) compared versus the null hypothesis that AUC = 0.05 and was assured using Regression analysis (Stepwise method). Cox regression analysis was used for evaluation of timing of referral as a predictor of mortality. Statistical analysis was carried out using SPSS (version 15, 2006 ; SPSS Inc., Chicago, Illinois, USA) for Windows statistical package. A P-value of less than 0.05 was considered statistically significant.
Results
The study included 370 CKD patients: 161 male (43.5%) and 209 female (56.5%), with a mean age of 61.7 ± 6.7 years (range: 45-77 years). ER was reported in 140 patients with a mean duration since the first nephrologist visit of 3.3 ± 0.8 months (range: 2-4 months), whereas LR was reported in 230 patients with a mean duration since the first nephrologist visit of 8.2 ± 1.5 months (range: 5-11 months). The mean BMI of the studied patients was 31.7 ± 2.4 kg/m 2 (range: 26.3-39.1 kg/m 2 ). Among the patients, 130 (35.1%) were of average weight, 215 (58.1%) were obese, and 25 (6.8%) were morbidly obese. Diabetic nephropathy was the most frequent underlying cause of CKD and was reported in 114 patients, hypertension was detected in 73 patients, and 26 patients were diabetic and hypertensive. Glomerulonephritis was the underlying disease in 50 patients and 117 patients had other diseases or an unknown underlying disease. There was a nonsignificant (P > 0.05) difference between the ER and LR groups as regards enrollment data ( Table  1) . Patients of LR group had significantly higher blood pressure measures compared those of the ER group (Table 1 , Fig. 1 ).
All patients had associated comorbidities with varying distributions; however, only 11 patients had comorbidities of 6 points on CCI, 23 patients had comorbidities of 3 points on CCI, 60 patients had comorbidities of 2 points on CCI, and the remaining patients had comorbidities of 1 point on CCI. There was a nonsignificant difference (χ 2 = 0.975, P > 0.05) between the studied groups as regards the differential frequency of associated comorbidities. Forty-one patients had more than one associated morbidity: five (3.6%) in the ER group and 36 (15.7%) in the LR group, with a significantly higher (χ 2 = 3.885, P < 0.05) frequency of patients with more than one comorbidity in the LR group (Table 2) .
Despite the non-significantly (χ 2 = 1.783, P > 0.05) higher number of patients had high CCI score in LR group, the calculated collective mean CCI score was significantly higher (Z = 2.811, P = 0.005) in the LR group (3.8 ± 1; range: 2-8) compared with the ER group (3.6 ± 0.8; range: 2-6, Fig. 2 ).
Laboratory data showed a significantly (Z = 4.029, P = 0.001) lower hemoglobin concentration (Fig. 3) and significantly higher serum phosphate (Z = 2.796, Data are presented as mean ± SD and numbers and percentages (in parentheses); DBP, diastolic blood pressure; SBP, systolic blood pressure.
Figure 1
Mean blood pressure measures of the studied patients categorized according to time of referral to a nephrologist. DBP, diastolic blood pressure; SBP, systolic blood pressure.
Figure 2
Mean (±SD) collective CCI score calculated in both study groups. CCI, Charlson comorbidity index.
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Figure 3
Mean (±SD) hemoglobin concentration of the studied patients categorized according to time of referral to a nephrologist.
Figure 4
Mean serum levels of calcium and phosphate in studied patients categorized according to time of referral to a nephrologist.
Figure 5
Lipid profile of studied patients categorized according to time of referral to a nephrologist. HDL, high-density lipoprotein; LDL, lowdensity lipoprotein. 
(3)
Data are presented as numbers and percentages (in parentheses); DM, Diabetes mellitus. P = 0.005; Fig. 4 ), total cholesterol (Z = 4.134, P = 0.001), and low-density lipoprotein (Z = 2.885, P = 0.004; Fig. 5 ) levels in the LR group compared with the ER group. Other parameters were nonsignificantly different between both groups but were in favor of the ER group (Table 3) . eGFR was significantly higher (Z = 9.325, P < 0.001) in the ER group (21.2 ± 7.5, range: 15-55 ml/min/1.73 m 2 ) compared with the LR group (14.5 ± 2.1, range: 11-21 ml/min/1.73 m 2 ).
During the entire study period, 31 patients died, yielding a total mortality rate of 8.4%: six from the ER group and 25 from the LR group, with mortality rates of 4.3 and 10.9%, respectively. The mortality rate was significantly higher (χ 2 = 3.78, P < 0.05) in the LR group compared with the ER group. Infection was the most frequent cause of death and was reported in 13 patients (mortality rate of 41.9%), followed by cardiovascular accidents in eight patients (mortality rate of 25.8%), an underlying malignant disease in four patients (mortality rate of 12.9%), development of hepatic coma in three patients, uncontrollable gastrointestinal bleeding in one patient, and acute pulmonary embolism in one patient.
Survival was found to be negatively correlated with time until referral to a nephrologist, age, CCI, systolic blood pressure (SBP), and multiplicity of associated The reported data is in accordance with previously reported literature on the impact of referral timing on outcome in CKD patients. Chen et al. [15] reported comorbidities, whereas it was found to be positively correlated with female sex and high eGFR ( Table 4) .
Verification of these parameters as predictors for mortality by ROC curve analysis showed that high CCI and low eGFR were significant specific predictors for mortality, whereas old age, LR, and high SBP were significant sensitive predictors for mortality (Table 5 , Fig. 6 ).
Regression analysis defined LR as the significant predictor for mortality in four models, old age in three models, low eGFR in two models, and high CCI in one model, (Table 6 ). In the Cox regression analysis, the survival rate among ER patients was significantly better than that among LR patients after adjusting for several risk factors (Fig. 7 ).
Discussion
The current study detected significantly lower eGFR and hemoglobin concentration; significantly higher serum levels of total cholesterol, low-density lipoprotein, and phosphate; and higher blood pressure measures in LR patients compared with ER patients. Concomitantly, throughout the follow-up period, the LR group showed a significantly higher mortality rate compared with the ER group. These data illustrate the burden of LR on CKD patients, who were mostly compromised as manifested by the finding that all patients had at least one associated comorbidity, despite the significantly higher total CCI score in the LR group compared with the ER group.
Moreover, survival was found to be negatively correlated with time until referral to nephrologist, age, CCI, SBP, and multiplicity of associated comorbidities, whereas it was positively correlated with female sex and high eGFR. Regression analysis defined LR as the persistently significant predictor for mortality, followed by old age, low eGFR, and high CCI. Cox regression analysis showed that survival rate in ER patients was significantly better than that in LR patients after adjusting for several risk factors. ROC curve analysis of studied parameters as predictors for mortality. CCI, Charlson comorbidity index; eGFR, estimated glomerular filtration rate; LR, late referral; ROC, receiver operating characteristic; SBP, systolic blood pressure.
Cox regression curve for survival probability in relation to time of referral.
Figure 7
that nephrology referral was the most significant factor associated with slowing of renal disease progression, followed by younger age and female sex, and patients had better control of diastolic blood pressure and sugar and lipid levels; more frequent use of angiotensinconverting enzyme inhibitors, angiotensin II receptor blockers, and statins; less frequent use of NSAIDs; and more serum creatinine measurements after nephrology referral. Chen et al. [16] found ER to be significantly associated with better clinical outcome and prolonged survival.
Smart and Titus [17] reviewed the Cochrane Central Register of Controlled Trials for studies on early versus late nephrology referral in adult patients with CKD and reported that 33% of patients were referred late, comparative mortality was higher among patients referred to a specialist late compared with those referred early, and ER was associated with better preparation and placement of dialysis access.
Boudville et al. [18] reported that kidney function and anemia were significantly associated with mortality on multivariate analysis, and after 18 months, 8.8% of patients with CKD were referred to a nephrologist; they concluded that despite the high prevalence of CKD among patients attending a geriatric outpatient clinic and its association with anemia and mortality, few of these patients were referred to a nephrologist.
Hommel et al. [19] reported LR of 38% of incident RRT patients; among these, 72% were treated in nonnephrology hospital departments and 91% in general practice before RRT was commenced, and fewer LRs received recommended pre-RRT treatment as judged by renin-angiotensin-system blockade, 32 versus 57%, or the vitamin-D analog alfacalcidol, 5 versus 30%. The 1-year mortality rate was higher among LRs, and 30% LRs versus 9% ERs had a significantly higher level of plasma creatinine (≤150% of upper reference limit) within 1-2 years before RRT commencement.
Kim et al. [20] found, after 2 years of follow-up of greater than 1000 Korean ESRD patients in general and patients with diabetes nephropathy, that the survival rate among ER patients was better than that among LR patients, patient survival was also significantly higher among ER patients than among LR patients, and with an increase in age, the risk for mortality was increased. Harel et al. [21] reported that the incidence of all-cause mortality was lower among severe acute kidney injury patients with early nephrology follow-up compared with those without ER, and they concluded that early nephrology follow-up after hospitalization in patients with acute kidney injury and temporary dialysis were associated with improved survival.
Multiple studies tried to explore the underlying causes for LR. Navaneethan et al. [22] found that age greater than 75 years, limited life expectancy, patient noncompliance, or refusal to consider dialysis influenced a primary care physician's decision to refer the patient to a nephrologist and may account for the high number of nonreferrals or LRs. Parameswaran et al. [23] reported that a large majority of patients with ESRD in India seek medical attention late, usually in advanced stages of CKD with uremic complications, and that LR is more frequent among younger patients and those with nondiabetic kidney disease and is associated with poor socioeconomic status, lack of education, and poor outcomes. Mendelssohn et al. [24] reported that suboptimal initiation of dialysis is common among ER patients and the benefits of ER are lost if dialysis is initiated suboptimally; hence, there is a need to identify factors that lead to suboptimal initiation of dialysis despite ER.
Hughes et al. [25] blamed not only patients but also nephrologists for initiation of dialysis in a suboptimal manner despite an extended period of predialysis care and ER and reported that factors contributing to suboptimal initiation despite ER included patientrelated delays (31.25%), acute kidney disease or CKD (31.25%), surgical delays (16.41%), late decision making (8.59%), and others (12.50%), with the percentage of optimal initiations with ERs among 14 nephrologists ranging from 33 to 72%.
Conclusion
ER of CKD patients to nephrologists significantly minimizes morbidities and improves the chances of survival, which is significantly affected by age, multiplicity of associated comorbidities, and GFR. Improving the knowledge of patients and general physicians on the hazards of LR to nephrologists will definitely improve the outcome of patients with CKD.
